These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30425481)

  • 1. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
    Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
    Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
    Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution.
    Kim CH; Sung SW; Lee ES; Kang TH; Yoon HY; Goo YT; Cho HR; Kim DY; Kang MJ; Choi YS; Lee S; Choi YW
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30360549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-Modification of RIPL Peptide-Conjugated Liposomes to Achieve Steric Stabilization and pH Sensitivity.
    Kwon YH; Shin TH; Jang MH; Yoon HY; Kang MH; Kang MJ; Choi YW
    J Nanosci Nanotechnol; 2017 Feb; 17(2):1008-17. PubMed ID: 29671978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
    Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Kang MH; Park MJ; Yoo HJ; hyuk KY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
    Eur J Pharm Biopharm; 2014 Aug; 87(3):489-99. PubMed ID: 24704199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S; Ishak RAH; Hathout RM; Mortada ND
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo.
    Wang H; Sun M; Li D; Yang X; Han C; Pan W
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):313-322. PubMed ID: 28362124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
    Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
    Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
    [No Abstract]   [Full Text] [Related]  

  • 12. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
    Nahak P; Gajbhiye RL; Karmakar G; Guha P; Roy B; Besra SE; Bikov AG; Akentiev AV; Noskov BA; Nag K; Jaisankar P; Panda AK
    Pharm Res; 2018 Aug; 35(10):198. PubMed ID: 30151753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G; Liu F; Jia E; Jia L; Zhang Y
    Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y; Zhao D; Yin Q
    Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.